International Safety and Quality of Parenteral Nutrition Summit: Introduction
American Journal of Health-System Pharmacy · 2024
DOI: 10.1093/ajhp/zxae076 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2024. Verfasst von Phil Ayers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Services, Department of Pharmacy, Baptist Medical Center, Jackson, MS, and University of Mississippi School of Pharmacy, Jackson, M…. Hauptthemen laut MEDLINE: Parenteral Nutrition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We would like to thank you for your interest in this supplement, Safety and Quality of Parenteral Nutrition: Translating Guidelines Into Clinical Practice Considering Different Organizational Settings, based on the International Safety and Quality of Parenteral Nutrition (PN) Summit held on November 8 to 10, 2021, at two locations (Charleston, SC, and Bad Homburg, Germany). A wide variety of international PN experts participated in the summit, including pharmacists (one pharmacist was also a PN patient), physicians, and a dietitian. Experts delivered presentations and discussed topics concerning improvements to the safety and quality of PN.1 The summit’s main objectives were to: Discuss challenges and strategies to ensure the safety, quality, and cost-effectiveness of PN in a variety of different geographical and organizational settings Investigate and compare methods for standardization of the PN process, particularly aspects related to standardization through greater use of commercially available multichamber bags (MCBs) and/or standardized compounding Examine aspects of the safety and quality of PN formulations, such as the composition of PN formulations and the better management of PN when component shortages occur The summit format consisted of presentations by international multidisciplinary experts on a variety of topics, followed by the formulation of related draft consensus statements. These statements were based on clinical and scientific evidence and, when evidence was lacking, on the practical and/or clinical experience of the experts. Next, the summit experts voted on the consensus statements anonymously, using a Likert-type scale. Thus, the consensus statements represent the opinion of the experts, not those of a national or international nutrition society nor formal guideline committee, and as such they complement formal guideline recommendations. The goal of this summit (as reflected in the articles contained within this supplement) was to bridge the gap between formal guideline recommendations from several nutrition societies and the preparation and use of PN in everyday practice—in the hospital pharmacy, intensive care unit (ICU), hospital ward, or patients’ home environment. The expert consensus statements and a summary of proceedings from the summit is the first article in this supplement.1 The topics covered by the summit are thereafter covered in more detail in the other articles, also based on the summit presentations, including additional information from the literature. Topics covered by these articles are as follows: parenteral nutrition in clinical practice: international challenges and strategies,2 parenteral nutrition in the hospital setting/short-term parenteral nutrition,3 parenteral nutrition in the home care setting/long-term parenteral nutrition,4 and safety and quality of parenteral nutrition: areas of improvement and future perspectives.5 It is clear from this summit that PN is an important therapeutic intervention. Patients may need PN for a variety of conditions that interfere with oral intake, digestion, or nutrient absorption, such as short bowel syndrome, bowel obstruction, severe acute pancreatitis, critical illness, major abdominal surgery, and cancer. Some patients may require temporary PN, but others may receive long-term therapy—or even lifelong PN in their own home environment. PN formulations are among the most complex medications used routinely in healthcare settings and thus have a high potential for errors, posing a possible risk to patient health. Moreover, to minimize these risks, standardization of the PN process has been advocated for some time. Standardization can be achieved using a variety of approaches encompassing both compounding and the more widespread use of MCBs, whether in the form of 2-chamber bags containing glucose/dextrose and amino acids, or 3-chamber bags containing glucose/dextrose, amino acids, and a lipid emulsion. At the summit, many differences emerged between PN practices according to geographical location. For example, in Europe a wider choice of lipid emulsions and 3-chamber bags are available than in the US, where compounding and/or the use of 2-chamber bags (with separate lipid emulsion infusions) are far more common. Regardless of the prevailing approach used, it is anticipated that reviewing these areas and formulating these recommendations will help to guide international PN practices. One such example was advice to move away from supplying first-generation pure soybean oil lipid emulsions to more modern lipid emulsions that also contain fish oil, in line with potential clinical outcome benefits in the literature.1,6-9 In conclusion, we trust that this information may help all healthcare professionals to improve PN safety and quality. Finally, we would like to thank Fresenius Kabi GmbH (Bad Homburg, Germany) for their generosity in funding the International Safety and Quality of PN Summit. Fresenius Kabi Deutschland GmbH and Fresenius Kabi USA provided financial support to organize and invite experts to participate as speakers, based on knowledge and international reputation within the areas of clinical nutrition, to the International Safety and Quality of Parenteral Nutrition Summit, as well as financial support for the development of this supplement. Fresenius Kabi had no involvement in the collection, analysis, and interpretation of data; or writing of the manuscript. Dr. Richard Clark (freelance medical writer, Dunchurch, UK) drafted the manuscript, and Dr. Martina Sintzel (mcs medical communication services, Erlenbach, Switzerland) provided editorial and consultancy services; all were funded by Fresenius Kabi. These services complied with international guidelines for Good Publication Practice (GPP2022). Dr. Ayers is a consultant and speakers bureau member for Fresenius Kabi, and has received speaker’s honoraria from Baxter. Dr. Wischmeyer has received investor-instigated grant funding related to his work from the National Institutes of Health, US Department of Defense, Abbott, Baxter, and Fresenius Kabi, Mend Inc., and Nutricia, consulting fees from Abbott, Baxter, Fresenius Kabi, Mend Inc, and Nutricia, and honoraria or travel expenses for CME lectures on improving nutrition care from Abbott, Baxter, DSM, Fresenius Kabi, Nestlé, and Nutricia. He has received an unrestricted gift donation for nutrition research from Musclesound and DSM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Pharmacy Services, Department of Pharmacy, Baptist Medical Center, Jackson, MS, and University of Mississippi School of Pharmacy, Jackson, MS, USA.
- Department of Anesthesiology and Surgery, Duke University School of Medicine, Durham, NC, USA.
Zitieren
APA
Ayers, P., & Wischmeyer, P. E. (2024). International Safety and Quality of Parenteral Nutrition Summit: Introduction. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxae076
Vancouver
Ayers P, Wischmeyer PE. International Safety and Quality of Parenteral Nutrition Summit: Introduction. American Journal of Health-System Pharmacy. 2024. doi:10.1093/ajhp/zxae076
BibTeX
@article{Ayers2024,
author = {Ayers, Phil and Wischmeyer, Paul E},
title = {International Safety and Quality of Parenteral Nutrition Summit: Introduction},
journal = {American Journal of Health-System Pharmacy},
year = {2024},
doi = {10.1093/ajhp/zxae076}
}
EUVIMED